Research identifies adipokines as significant predictors of metabolic syndrome, indicating age and BMI impact risk assessment.
Galectin-1, adiponectin, and the A/L ratio are associated with MetS, with the A/L serving as a robust independent predictor. These findings underscore the importance of adipokine profiling, particularly in stratified age and BMI groups, for early identification of metabolic risk.
No takes yet. Share an insight, caveat, or question.
Abdulateef et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: